Content area

Abstract

Myristica fragrans, also known as nutmeg, is a spice that cures various diseases. This study aimed to synthesize silver nanoparticles from a hydroethanolic extract of Myristica fragrans seeds (MFHE) and evaluate their anti-diabetic properties. To MFHE, AgNO3 solution was added and exposed to sunlight to produce silver nanoparticles from hydroethanolic seed extract of Myristica fragrans (MFHENP). The MFHENP was characterized by numerous techniques. UV-visible spectroscopy confirmed the formation of silver nanoparticles by the absorption peak at 430nm. Scanning electron microscopy (SEM) studies revealed the shape and size of the particles at the range of 50–60nm. Energy-dispersive X-ray spectroscopy (EDX) disclosed the presence of silver ions. X-ray diffraction spectrum confirmed the crystalline nature of silver nanoparticles by the peak at 39°. FTIR analysis revealed the functional groups present in MFHE as well as in MFHENP and zeta potential analysis was found to be 14mV. Furthermore, in vitro anti-diabetic activity was investigated. MFHENP showed significant efficiency against the inhibition of alpha-amylase and alpha-glucosidase enzymes and also MFHENP retarded the glucose transport across the membrane which is analyzed by glucose diffusion and glucose uptake assays. Acarbose is used as a standard for all these methods and MFHENP efficiency proves their therapeutic potential for the treatment of diabetes mellitus.

Details

Title
Anti-Diabetic Activity of Silver Nanoparticles Synthesized from the Hydroethanolic Extract of Myristica fragrans Seeds
Author
Perumalsamy Ramya 1   VIAFID ORCID Logo  ; Krishnadhas Lavanya 1 

 PSG College of Arts & Science, Department of Biochemistry, Coimbatore, India (GRID:grid.411677.2) (ISNI:0000 0000 8735 2850) 
Pages
1136-1148
Publication year
2022
Publication date
Mar 2022
Publisher
Springer Nature B.V.
ISSN
02732289
e-ISSN
15590291
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2628014531
Copyright
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.